DURECT Corporation

NASDAQ:DRRX

1.35 (USD) • At close November 4, 2024
Bedrijfsnaam DURECT Corporation
Symbool DRRX
Munteenheid USD
Prijs 1.35
Beurswaarde 41,903,190
Dividendpercentage 0%
52-weken bereik 0.47 - 2.77
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. James E. Brown D.V.M.
Website https://www.durect.com

An error occurred while fetching data.

Over DURECT Corporation

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small

Vergelijkbare Aandelen

Ardelyx, Inc. logo

Ardelyx, Inc.

ARDX

5.89 USD

Axcella Health Inc. logo

Axcella Health Inc.

AXLA

4.58 USD

iCAD, Inc. logo

iCAD, Inc.

ICAD

1.74 USD

Aeglea BioTherapeutics, Inc. logo

Aeglea BioTherapeutics, Inc.

AGLE

12.01 USD

Aptose Biosciences Inc. logo

Aptose Biosciences Inc.

APTO

0.398 USD

LAVA Therapeutics N.V. logo

LAVA Therapeutics N.V.

LVTX

1.77 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

TRVI

3.04 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)